Furthermore, a high level of IGFBP-2 is associated with higher risk of peripancreas lymph node metastasis and it has been identified as an independent prognostic factor in pancreatic cancer [37]. Here, IGFBP2 is linked to metastatic malignant neoplasm in the lymph nodes.